Nirsevimab 43835-0051-02
- Manufacturer
- Novo Nordisk Production Belgium Sa
- Dosage Form
- Injection, Solution
- Product Type
- Drug For Further Processing
- Marketing Start
- October 1, 2024
- Listing Expires
- December 31, 2027
Active Ingredients
| Ingredient | Strength |
|---|---|
| Nirsevimab | 50 mg/.5mL |
Selected Package
43835-0051-02Selected3 CONTAINER in 1 BOX (43835-0051-2) / 100 SYRINGE, GLASS in 1 CONTAINER / .5 mL in 1 SYRINGE, GLASS